Concepedia

Author

Taketoshi Shimada

Kyoto Prefectural University of Medicine

Also Known As

T Shimada, T. Shimada, Taketoshi SHIMADA, Taketoshi Shimada

90

Publications

1.1K

Citations

15

H-Index

40

Concepts

All Affiliations

Kyoto Prefectural University of MedicineKeio UniversityThe University of TokyoShiga University of Medical ScienceFuji Chemical Industries (Japan)
TS

About

Taketoshi Shimada is an author at Kyoto Prefectural University of Medicine specializing in medicine, tumor microenvironment, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

461

2

Cell Biology

5

5

341

3

Immunology

4

4

164

4

Natural Sciences

1

1

37

5

Allergy

1

1

12

Taketoshi Shimada

×

22

Publications

968

Citations

15

H-Index

YearCitations

Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.

Hiroyuki Nakamura, Hirohisa Ueno, Kaname Yamashita,

PubMed

1999

158

Interleukin-27 Activates Natural Killer Cells and Suppresses NK-Resistant Head and Neck Squamous Cell Carcinoma through Inducing Antibody-Dependent Cellular Cytotoxicity

Masahiro Matsui, Tsunao Kishida, Hiroshi Nakano,

Cancer Research

2009

105

Characterization of a truncated recombinant form of human membrane type 3 matrix metalloproteinase

Taketoshi Shimada, Hiroyuki Nakamura, Eiko Ohuchi,

European Journal of Biochemistry

1999

103

Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis <i>via</i> CCR4/CCL22 in head and neck squamous cell carcinoma

Takahiro Tsujikawa, Tomonori Yaguchi, Gaku Ohmura,

International Journal of Cancer

2012

80

Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human oral squamous cell carcinomas: Implications for lymph node metastasis

Taketoshi Shimada, Hiroyuki Nakamura, Kaname Yamashita,

Clinical & Experimental Metastasis

2000

74

RECQL1 and WRN Proteins Are Potential Therapeutic Targets in Head and Neck Squamous Cell Carcinoma

Akihito Arai, Tokuhiro Chano, Kazunobu Futami,

Cancer Research

2011

65

Interleukin-21 triggers both cellular and humoral immune responses leading to therapeutic antitumor effects against head and neck squamous cell carcinoma

Hiroshi Nakano, Tsunao Kishida, Hidetsugu Asada,

The Journal of Gene Medicine

2005

61

Activation of pro‐MMP‐2 mediated by MT1‐MMP in human salivary gland carcinomas: possible regulation of pro‐MMP‐2 activation by TIMP‐2

Kaori Kayano, Taketoshi Shimada, Takashi Shinomiya,

The Journal of Pathology

2004

37

Expression of CC-chemokine receptor 7 (CCR7) and CXC-chemokine receptor 4 (CXCR4) in head and neck squamous cell carcinoma

Masaru Ueda, Taketoshi Shimada, Yoshiko Goto,

Auris Nasus Larynx

2009

37

RB1CC1 activates the promoter and expression of RB1 in human cancer

Kaichiro Ikebuchi, Tokuhiro Chano, Yasuko Ochi,

International Journal of Cancer

2009

37

Page 1